Matthew Sims, MD, Ph.D
Disclosures: Primary Investigator through Beaumont-Curetis|Primary Investigator through Beaumont-Merck and Company, Inc.|Primary Investigator through Beaumont-Genentech, Inc.|Primary Investigator through Beaumont-Seres|Sub Investigator through Beaumont-Epigenomics|Primary Investigator through Beaumont-Crestovo (name changed to Finch)|Primary Investigator through Beaumont-Contrafect|Primary Investigator through Beaumont-Diasorin Molecular|Sub-Investigator through Beaumont-Shire|Primary Investigator through Beaumont-Janssen |Primary Investigator through Beaumont-Leonard-Meron Biosciences|Primary Investigator through Beaumont-Prenosis|Primary Investigator through Beaumont-Summit Therapeutics|Primary Investigator through Beaumont-Kinevant|Primary Investigator through Beaumont-Regeneron
No Bio Available.